SY
Synovics Pharmaceuticals, Inc.
SYVC · OTC
$0.00 +0.00% (+$0.00)
Piotroski F-Score Weak
3/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
50 /100
Moderate Beta -0.29x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SYVC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher J. Flynn
Employees
155
Headquarters
Fort Lauderdale